Community Medicine (PSM) · National Health Programmes (NTEP, NVBDCP, NACP, NIS, RMNCH+A)

A 32-year-old HIV-positive patient newly enrolled in the NTEP has a sputum Gene Xpert MTB/RIF result: MTB DETECTED; RIF resistance DETECTED. What is the correct NTEP treatment regimen?

  • A Conventional MDR-TB regimen with 6 drugs for 18-24 months
  • B Standard 2HRZE/4HR regimen
  • C Shorter oral BPaLM regimen (Bedaquiline, Pretomanid, Linezolid, Moxifloxacin)
  • D Pre-XDR regimen with Imipenem-Cilastatin plus Delamanid
Correct answer: C. Shorter oral BPaLM regimen (Bedaquiline, Pretomanid, Linezolid, Moxifloxacin)

Explanation

India's NTEP (2023 guidelines) has adopted the shorter all-oral BPaLM (Bedaquiline, Pretomanid, Linezolid, Moxifloxacin) regimen for confirmed RIF-resistant/MDR-TB patients, replacing the longer conventional regimen. BPaLM is 6 months in duration, significantly shorter than the previous 18-24-month regimen, with improved outcomes and oral-only route. The standard 2HRZE/4HR regimen is for DS-TB only. Pre-XDR TB requires BPaL ± other drugs.

Reference: Park's Textbook of Preventive and Social Medicine, 27th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 23,000+ MCQs.

Start free → Log in

More National Health Programmes (NTEP, NVBDCP, NACP, NIS, RMNCH+A) MCQs

See all National Health Programmes (NTEP, NVBDCP, NACP, NIS, RMNCH+A) MCQs →